Esmolol Hydrochloride

CAS 81161-17-3 7 current records 3 historicalSmall Molecule

Who holds supplier records for Esmolol Hydrochloride? 7 organisations hold a current record for Esmolol Hydrochloride: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3), France (2), Canada (1) and Israel (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Esmolol Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/esmolol-hydrochloride

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Esmolol Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Esmolol Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (3)

Organisations whose Type II DMFs for Esmolol Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • Inactive DMF 15743 · filed Nov 2001
  • UPJOHN CHEM CO
    Inactive DMF 5224 · filed Jan 1984
  • GANES CHEMICALS INC PENNSVILLE DIV
    Inactive DMF 5126 · filed Nov 1983

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Esmolol Hydrochloride is a cardioselective beta-1 receptor blocker used primarily for the rapid control of heart rate in atrial fibrillation, atrial flutter, and sinus tachycardia. Due to its short-acting nature, it is often utilized in acute care settings.

Chemical identity

IUPAC name
methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate;hydrochloride
Canonical SMILES
CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl
InChIKey
GEKNCWBANDDJJL-UHFFFAOYSA-N
Synonyms
Brevibloc API, asl-8052, brevibloc, clol, esmolol hcl

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
beta-Adrenergic Blocker
Mechanism of action
Adrenergic beta-Antagonists

Therapeutic areas

CardiovascularArrhythmiaHypertension

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Esmolol Hydrochloride?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Esmolol Hydrochloride: CHEMWERTH INC (France), DELMAR CHEMICALS INC (Canada), FINORGA SAS (France), GLOBAL CALCIUM PRIVATE LTD (India), MEHTA API Pvt. Ltd. (India), MSN Laboratories Private Limited (India) and Taro Pharmaceutical Industries Ltd. (Israel). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Esmolol Hydrochloride Drug Master Files are active?

CHEMWERTH INC (DMF 16053), DELMAR CHEMICALS INC (DMF 4475), FINORGA SAS (DMF 6868), GLOBAL CALCIUM PRIVATE LTD (DMF 36877), MEHTA API Pvt. Ltd. (DMF 39475), MSN Laboratories Private Limited (DMF 26024) and Taro Pharmaceutical Industries Ltd. (DMF 16863). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Esmolol Hydrochloride records mean?

3 organisations have only inactive Type II DMFs for Esmolol Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Esmolol Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Esmolol Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.